GRP
SNOA icon

Global Retirement Partners’s Sonoma Pharmaceuticals SNOA Stock Holding History

Global Retirement Partners’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.81K Buy
772
+334
+76% +$1.23K ﹤0.01% 3622
2025
Q3 		$1.7K Buy
+438
New +$1.72K ﹤0.01% 3369

Other funds holding SNOA

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Global Retirement Partners's SNOA Position: Q4 2025 in Review

Global Retirement Partners increased its Sonoma Pharmaceuticals (SNOA) stake by 76% in Q4 2025, buying an estimated $1.23K and bringing the position to 772 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

Global Retirement Partners first reported a position in SNOA in Q3 2025 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold SNOA as of Q4 2025.

  • Global Retirement Partners held 772 shares of Sonoma Pharmaceuticals worth $2.81K as of Q4 2025.
  • Global Retirement Partners bought 334 Sonoma Pharmaceuticals shares in Q4 2025, an estimated $1.23K.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3622 holding.
  • Global Retirement Partners first reported a position in Sonoma Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.